The role of neuromuscular blockers in ARDS: Benefits and risks

Current Opinion in Critical Care

Volumn 18, Issue 5, 2012, Pages 495-502

  Hraiech, Sami ^a,b   Forel, Jean Marie ^a,b   Papazian, Laurent ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

Author keywords

Acute respiratory distress syndrome; ICU acquired weakness; Mechanical ventilation; Neuromuscular blocking agents

Indexed keywords

CISATRACURIUM; HYDROCORTISONE; METHYLPREDNISOLONE; PANCURONIUM; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLAXIS; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; DRUG EFFECT; DRUG USE; HUMAN; HYPERSENSITIVITY REACTION; MUSCLE WEAKNESS; MYOPATHY; OUTCOME ASSESSMENT; OXYGENATION; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT OUTCOME;

ANAPHYLAXIS; DIAPHRAGM; HUMANS; IATROGENIC DISEASE; INTENSIVE CARE UNITS; NEUROMUSCULAR BLOCKING AGENTS; PULMONARY ATELECTASIS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS;

EID: 84865987844     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328357efe1     Document Type: Review

References (48)

1. Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009; 179:220-227.
2. Esan A, Hess DR, Raoof S, et al. Severe hypoxemic respiratory failure: part 1: ventilatory strategies. Chest 2010; 137:1203-1216.
3. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301-1308.
4. Arroliga A, Frutos-Vivar F, Hall J, et al. Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 2005; 128:496-506. (Pubitemid 41140473)
5. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30:142-156. (Pubitemid 34112189)
6. Vender JS, Szokol JW, Murphy GS, et al. Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit CareMed 2004; 32:S554-S561. (Pubitemid 39489029)
7. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107-1116.
8. Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive endexpiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327-336.
9. Arroliga AC, Thompson BT, Ancukiewicz M, et al. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2008; 36:1083-1088. (Pubitemid 351482720)
10. Raoof S, Goulet K, Esan A, et al. Severe hypoxemic respiratory failure: part 2: nonventilatory strategies. Chest 2010; 137:1437-1448.
11. Needham CJ, Brindley PG. Best evidence in critical care medicine: the role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Can J Anaesth 2012; 59:105-108.
12. Slutsky AS. Neuromuscular blocking agents in ARDS. N Engl J Med 2010; 363:1176-1180.
13. Mehta S, Granton J, MacDonald RJ, et al. High-frequency oscillatory ventilation in adults: the Toronto experience. Chest 2004; 126:518-527. (Pubitemid 39093438)
14. Pollitzer MJ, Reynolds EO, Shaw DG, Thomas RM. Pancuronium during mechanical ventilation speeds recovery of lungs of infants with hyaline membrane disease. Lancet 1981; 1:346-348. (Pubitemid 11167586)
15. Coggeshall JW, Marini JJ, Newman JH. Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Intern Med 1985; 145:1718-1720. (Pubitemid 16258217)
16. Philips JB, Setzer ES, Drummond WH, et al. Hypoxaemia in ventilated neonates after pancuronium paralysis. Lancet 1979; 1:877. (Pubitemid 9165959)
17. Lagneau F, D'honneur G, Plaud B, et al. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med 2002; 28:1735-1741. (Pubitemid 35435475)
18. Gainnier M, Roch A, Forel JM, et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32:113-119. (Pubitemid 38125571)
19. Forel JM, Roch A, Marin V, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34:2749-2757. (Pubitemid 44610939)
20. Tokics L, Hedenstierna G, Svensson L, et al. V/Q distribution and correlation to atelectasis in anesthetized paralyzed humans. J Appl Physiol 1996; 81:1822-1833. (Pubitemid 26349644)
21. Tremblay LN, Slutsky AS. Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med 2006; 32:24-33. (Pubitemid 43039374)
22. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:1-6. (Pubitemid 40116529)
23. Yoshida T, Uchiyama A, Matsuura N, et al. Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: high transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med 2012; 40:1578-1585.
24. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10:931-941.
25. Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care 2005; 11:381-390. (Pubitemid 41248314)
26. Bolton CF. The discovery of critical illness polyneuropathy: a memoir. Can J Neurol Sci 2010; 37:431-438.
27. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. J Am Med Assoc 2002; 288:2859-2867. (Pubitemid 35425072)
28. Latronico N, Guarneri B. Critical illness myopathy and neuropathy. Minerva Anesthesiol 2008; 74:319-323. (Pubitemid 352037798)
29. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287:834-843.
30. Kindler CH, Verotta D, Gray AT, et al. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology 2000; 92:821-832. (Pubitemid 30130185)
31. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99:176-184.
32. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005; 11:126-132. (Pubitemid 40488611)
33. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-1353. (Pubitemid 40570499)
34. Bercker S, Weber-Carstens S, Deja M, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33:711-715.
35. De Jonghe B, Lacherade JC, Sharshar T, et al. Intensive care unit-acquired weakness: risk factors and prevention. Crit Care Med 2009; 37:S309-315.
36. Weber-Carstens S, Deja M, Koch S, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 2010; 14:R119.
37. Griffiths RD, Hall J.B. Intensive care unit-acquired weakness. Crit Care Med 2010; 38:779-787.
38. Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL, et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005; 33:349-354. (Pubitemid 40216548)
39. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175:480-489. (Pubitemid 46354252)
40. Testelmans D, Maes K, Wouters P, et al. Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function. Intensive Care Med 2007; 33:872-879. (Pubitemid 46675321)
41. Hansen-Flaschen J. Neuromuscular blockade in the intensive care unit. More than we bargained for. Am Rev Respir Dis 1993; 147:234-236. (Pubitemid 23025946)
42. Brismar B, Hedenstierna G, Lundquist H, et al. Pulmonary densities during anesthesia with muscular relaxation-a proposal of atelectasis. Anesthesiology 1985; 62:422-428. (Pubitemid 15111323)
43. Hedenstierna G, Strandberg A, Brismar B, et al. Functional residual capacity, thoracoabdominal dimensions, and central blood volume during general anesthesia with muscle paralysis and mechanical ventilation. Anesthesiology 1985; 62:247-254. (Pubitemid 15101872)
44. Dong SW, Mertes PM, Petitpain N, et al. Hypersensitivity reactions during anaesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol 2012 [Epub ahead of print].
45. Hardin KA, Seyal M, Stewart T, et al. Sleep in critically ill chemically paralyzed patients requiring mechanical ventilation. Chest 2006; 129:1468-1477. (Pubitemid 43894974)
46. Ballard N, Robley L, Barrett D, et al. Patients' recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 2006; 15:86-94. (Pubitemid 43498194)
47. Inoue S, Kawaguchi M, Sasaoka N, et al. Effects of neuromuscular block on systemic and cerebral hemodynamics and bispectral index during moderate or deep sedation in critically ill patients. Intensive Care Med 2006; 32:391-397. (Pubitemid 43289647)
48. Nelson BJ, Weinert CR, Bury CL, et al. Intensive care unit drug use and subsequent quality of life in acute lung injury patients. Crit Care Med 2000; 28:3626-3630.